When comparing BCLC-B and C vs BCLC-D treated patients, although it did not reach statistical significance, a better survival curve was observed in BCLC-B/C patients with a HR of 0.63 (CI: 0.31-1.27; P = 0.19).
← all excerpts
Intermediate-advanced hepatocellular carcinoma in Argentina: Treatment and survival analysis.
1
0.1900
0.1900